Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Ductal Carcinoma In Situ Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
DNA Topoisomerase II (EC 5.99.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Lipase (EC 3.1.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
PharmaSphere: US Healthcare Policy Update – Impact Analysis of the Affordable Care Act on Stakeholders